Thomas Uhde to Clonidine
This is a "connection" page, showing publications Thomas Uhde has written about Clonidine.
Connection Strength
1.195
-
Heart rate and QT interval variability: abnormal alpha-2 adrenergic function in patients with panic disorder. Psychiatry Res. 2003 Dec 01; 121(2):185-96.
Score: 0.217
-
Growth hormone response to clonidine in the nervous pointer dog model of anxiety. Anxiety. 1994; 1(2):45-9.
Score: 0.109
-
Growth hormone response to intravenous clonidine in social phobia: comparison to patients with panic disorder and healthy volunteers. Biol Psychiatry. 1993 Nov 01; 34(9):591-5.
Score: 0.108
-
Blunted growth hormone responses to growth hormone-releasing factor and to clonidine in panic disorder. Am J Psychiatry. 1993 Feb; 150(2):336-7.
Score: 0.102
-
Growth hormone (GH) response to clonidine and growth hormone releasing factor (GRF) in normal controls. Psychoneuroendocrinology. 1990; 15(4):253-9.
Score: 0.083
-
Behavioral and physiologic effects of short-term and long-term administration of clonidine in panic disorder. Arch Gen Psychiatry. 1989 Feb; 46(2):170-7.
Score: 0.078
-
Cortisol response to clonidine in panic disorder: comparison with depressed patients and normal controls. Biol Psychiatry. 1988 Jul; 24(3):322-30.
Score: 0.075
-
Blunted growth hormone response to clonidine in panic disorder patients. Biol Psychiatry. 1986 Sep; 21(11):1081-5.
Score: 0.066
-
New studies and perspectives on the noradrenergic receptor system in depression: effects of the alpha 2-adrenergic agonist clonidine. Biol Psychiatry. 1984 Feb; 19(2):131-56.
Score: 0.055
-
Clonidine and psychophysical pain. Lancet. 1980 Dec 20-27; 2(8208-8209):1375.
Score: 0.044
-
Clonidine suppresses the opioid abstinence syndrome without clonidine-withdrawal symptoms: a blind inpatient study. Psychiatry Res. 1980 Mar; 2(1):37-47.
Score: 0.042
-
Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med. 1994 May 19; 330(20):1411-7.
Score: 0.028
-
Evidence for hypothalamo-growth hormone dysfunction in panic disorder: profile of growth hormone (GH) responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH in panic disorder patients versus healthy volunteers. Neuropsychopharmacology. 1992 Feb; 6(2):101-18.
Score: 0.024
-
Clonidine reduces plasma melatonin levels. J Pharm Pharmacol. 1986 Jul; 38(7):555-6.
Score: 0.016
-
Biological alterations in the primary affective disorders and other tricyclic-responsive disorders. Prog Neuropsychopharmacol Biol Psychiatry. 1985; 9(1):15-24.
Score: 0.015
-
Differential inhibitory noradrenergic responses to clonidine in 25 depressed patients and 25 normal control subjects. Am J Psychiatry. 1984 Jun; 141(6):733-41.
Score: 0.014
-
Fear and anxiety: relationship to noradrenergic function. Psychopathology. 1984; 17 Suppl 3:8-23.
Score: 0.014
-
Plasma cortisol responses to clonidine in depressed patients and controls. Evidence for a possible alteration in noradrenergic-neuroendocrine relationships. Arch Gen Psychiatry. 1984 Jan; 41(1):63-8.
Score: 0.014
-
Growth hormone response to clonidine in obsessive-compulsive patients. Br J Psychiatry. 1983 Feb; 142:184-7.
Score: 0.013
-
[Biochemical aspects of anxiety]. Sem Hop. 1982 Dec 02; 58(44):2573-9.
Score: 0.013
-
Evaluation of alpha-adrenergic responsiveness to clonidine challenge and noradrenergic metabolism in the affective disorders and their treatment. Psychopharmacol Bull. 1982 Oct; 18(4):118-9.
Score: 0.013
-
Growth hormone response to clonidine unchanged by chronic clorgyline treatment. Psychiatry Res. 1982 Oct; 7(2):139-44.
Score: 0.013
-
Possible subsensitization of alpha 2-adrenergic receptors by chronic monoamine oxidase inhibitor treatment in psychiatric patients. Psychiatry Res. 1982 Jun; 6(3):293-302.
Score: 0.012
-
Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls. Psychiatry Res. 1982 Apr; 6(2):171-83.
Score: 0.012
-
Noradrenergic challenges in the affective disorders. J Clin Psychopharmacol. 1981 Jul; 1(4):193-206.
Score: 0.011
-
Extreme elevations in plasma norepinephrine associated with decreased alpha-adrenergic responsiveness in major depressive disorder: two case reports. J Clin Psychopharmacol. 1983 Feb; 3(1):39-41.
Score: 0.003
-
Clinical studies of monoamine receptors in the affective disorders and receptor changes with antidepressant treatment. Prog Neuropsychopharmacol Biol Psychiatry. 1983; 7(2-3):249-61.
Score: 0.003